Publications

Search our bibliography using the filters on the right-hand side.

Displaying 101 through 132 of 132 publications.

Curry SJ, Fiore MC, West R, Sullivan SD, Nonnemaker J, Neighbors D, Zhou X, Jourdan S, Brouard R. Preliminary data from assessment toward tobacco economical and medical prospective trial (ATTEMPT)—A global longitudinal cohort study of the natural history of quit attempts. Poster presented at the 10th Annual Scientific Sessions of the Society for Research on Nicotine and Tobacco; February 2004. Scottsdale, AZ.

Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Jan 1;20(12):1883-93. doi: 10.1185/030079904X11510.

Neighbors DM, McCory D, Pesa J. Cost-effectiveness and budget impact of zolmitriptan nasal spray. Poster presented at the 2003 AMCP Educational Conference; October 2003. Montreal, Canada.

Degen K, Neighbors DM, Irish W, Lopez R. Inpatient chart abstraction study of atypical antipsychotic resources and costs. Poster presented at the American Psychiatric Association 54th Institute on Psychiatric Services; October 2002. Chicago, IL.

Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Paul J. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 18th International Conference on Pharmacoepidemiology; August 2002. Edinburgh, Scotland.

Ortiz M, Neighbors DM. Collecting evidence of equivalence: implications for economic analyses. Presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA.

Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Degen K. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(1):216.

Neighbors D, Irish WD, Lopez R, Degen K, Swann A, Grogg A. Inpatient medication utilization and costs of risperidone, olanzapine, and quetiapine: a retrospective chart abstraction study. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(3):234.

Irish WD, Neighbors D, Ortiz M. Evaluating therapeutic equivalence using meta analysis: implications for economic analysis. Poster presented at the Symposium on Meta Analysis of Medical Data sponsored by Mathematical Sciences Research Institute; 2002. Berkeley, CA.

Lehmann K, Radbruch L, Gockel HH, Neighbors D, Nuyts G. Costs of opioid therapy for chronic nonmalignant pain in Germany: an economic model comparing transdermal fentanyl (Duragesic) with controlled release morphine. Eur J Health Econ. 2002;3:111-9. doi: 10.1007/s10198-002-0097-6.

Irish WD, Neighbors DM, Lopez RB. Using propensity scores to adjust for treatment selection bias: review of methods plus an extension for use in studies with three or more treatment groups. Presented at the 2001 ISPOR 4th Annual European Congress; November 11, 2001. Cannes, France.

Mauskopf JA, Bell LN, Neighbors DM, Dombeck M. Estimating the return on investment for tuberculosis drugs. Poster presented at the 2001 ISPOR 4th Annual European Congress; November 11, 2001. Cannes, France. [abstract] Value Health. 2001 Sep; 4(6):446.

Neighbors DM, Bell TJ, Wilson J, Dodd SL. Economic evaluation of the fentanyl transdermal system for the treatment of chronic moderate to severe pain. J Pain Symptom Manage. 2001 Feb 1;21(2):129-43. doi: 10.1016/s0885-3924(00)00247-5.

Neighbors DM, Dodd SL. Re: economic evaluation of fentanyl - Response. J Pain Symptom Manage. 2001 Jan 1;22(1):541-3.

Neighbors DM, Lopez R, Ingham M, Bell TJ. A Canadian adaptation of a decision analytic model for the economic evaluation of opioids for chronic pain. Poster presented at the 2000 ISPOR 3rd Annual European Congress; November 2000. Antwerp, Belgium.

Finkelstein E, Neighbors DM, Bradley C, Candrilli SD. Medical resource utilization and costs of distinct episodes of colon cancer. Poster presented at the 2nd European Conference on the Economics of Cancer; September 2000. Brussels, Belgium.

Mauskopf JA, Cates SC, Griffin AD, Neighbors DM, Lamb SC, Rutherford C. Cost-effectiveness of zanamivir for the treatment of influenza in a high-risk population in Australia. Pharmacoeconomics. 2000 Jun;17(6):611-20. doi: 10.2165/00019053-200017060-00007.

Earnshaw SR, Neighbors DM, Bell LN, Bhattacharyya SK. Treatment guidelines compared to clinical practice for acute muscular low back pain. Poster presented at the 2000 ISPOR 5th Annual International Meeting; May 20, 2000. Arlington, VA.

Neighbors DM, Earnshaw SR, Bell L, Bhattacharyya SK. A model to perform economic evaluations of interventions for acute muscular low back pain. Poster presented at the 2000 ISPOR 5th Annual International Meeting; May 20, 2000. Arlington, VA.

Neighbors DM, Candrilli SD. Concomitant medication costing using clinical trial data: a case study. Presented at the 2000 ISPOR 5th Annual International Meeting; May 2000. Arlington, VA.

Neighbors DM. Potential for bias when using clinical trial adverse event rates to estimate toxicity costs. Presented at the 1999 ISPOR 2nd Annual European Congress; November 1999. Edinburgh, Scotland.

Neighbors DM, Downs KE. Medical resource use data collection in clinical trials. Presented at the DIA Meeting Session Economic Assessment in Clinical Trials: Design and Analysis; November 1999. Orlando, FL.

Neighbors DM, Bell T, Wilson TJ, Dodd SL. A three-phased decision analytic model for the economic evaluation of opioid therapy for chronic pain. Poster presented at the 1999 ISPOR 4th Annual International Meeting; May 1999. Arlington, VA.

Neighbors D, Buckingham T, Greiner W, Schulenburg J. Potential cost savings of the 4 French infiniti catheter in diagnostic coronary angiography. Poster presented at the Inaugural European Congress of the International Society for Pharmacoeconomics and Outcomes Research; December 1998. Cologne, Germany. [abstract] Value Health. 1999 Jan; 2(1):25. doi: 10.1016/S1098-3015(11)70103-6

Neighbors D. Clinical benefit endpoints in trials for the treatment of non-small cell lung cancer and hormone-refractory prostate cancer. Presented at the Investigator Meeting; 1998. San Diego, CA.

Neighbors D. Pharmacoeconomic endpoints in FUMA3007: a randomized, open-label study comparing a 28-day oral regimen of 5-fluorouracil plus 776c85 to intravenous gemcitabine for the first-line treatment of patients with unresectable advanced adenocarcinoma of the pancreas. Presented at the Investigator Meeting; 1997. Atlanta, GA.

Smith T, Hillner B, Neighbors DM, McSorley P, LeChevalier T. An economic evaluation of a randomized clinical trial comparing vinorelbine, vinorelbine plus cisplatin, and vindesine plus cisplatin for non-small cell lung cancer. J Clin Oncol. 1995;13(9):2166-73. doi: 10.1200/JCO.1995.13.9.2166.

Neighbors D. Collection of medical resource use data in MA1A2001: a randomized trial of panorex plus 5-fu plus levamisole versus 5-fu plus levamisole in patients with surgically resected stage III carcinoma of the colon. Presented at the Investigator Meeting; 1995.

Neighbors D. Development and use of interactive drug value models. Presented at the UNC School of Pharmacy; 1994. Chapel Hill, NC.

Neighbors D, Mauskopf JA. Importance of quality of life and cost-effectiveness studies in new drug development. Presented at the Southeast Regional Meeting of the American Association of Pharmaceutical Scientists; 1994. Research Triangle Park, NC.

French M, Neighbors D, Carswell L, Williams R, Bush L. A model for estimating industry compliance costs of food labeling regulations. Agribusiness: An International Journal. 1993;8(2):165-86.

French M, Neighbors D. A model to estimate the compliance costs of food labeling regulations. In: J.A. Caswell, editors. The economics of food safety. New York: United States. New York: Elsevier Science Publishing Co, Inc; 1991. p.299-325.